VERA Competitors & Alternatives
Compare Vera Therapeutics Inc with similar stocks in the same industry
Biotechnology
VERA
Main Stock$27.99
Tradestie Score
54
Market Cap
$1.84B
Analyst Upside
+165.1%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.70
|
$2.23B | - | 52 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.51
|
$2.22B | - | 66 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$50.08
|
$2.21B | - | 66 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.41
|
$2.18B | - | 56 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$12.28
|
$2.08B | - | 50 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.73
|
$2.02B | - | 46 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.21
|
$2.01B | - | 46 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.21
|
$1.97B | - | 59 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.50
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$65.25
|
$1.92B | - | 58 | Compare |
More VERA Analysis
Data updated: Oct 25, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry